Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Stage IV Colon Cancer
NCT05921942Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in colon cancer (2 arms), sponsored by Ain Shams University. Primary endpoints: Disease Control Rate at 6 months and Progression Free Survival at 1 year. Started Apr 2020; status: completed.
02
Drugs
metformin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT05921942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05921942.